LIVZON PHARMA (01513) has accumulated repurchased 9.426 million shares of A shares.
Lizhu Pharmaceutical (01513) announced that as of February 28, 2025, the company has completed the centralized auction trading...
LIVZON PHARMA (01513) announced that as of February 28, 2025, the company repurchased a total of 9.426 million A shares through centralized bidding trading, accounting for 1.03% of the total share capital. The highest purchase price was RMB 38.37 per share, the lowest price was RMB 35.18 per share, and the total amount of funds used was RMB 342 million (excluding transaction costs). The repurchase mentioned above complies with the company's established share repurchase program.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


